Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA‐REG OUTCOME trial

AIM: To investigate the association of the Thrombolysis In Myocardial Infarction (TIMI) Risk Score for Heart Failure in Diabetes (TRS‐HF(DM)) with mortality using data from the EMPA‐REG OUTCOME trial. MATERIALS AND METHODS: In EMPA‐REG OUTCOME, patients with type 2 diabetes and atherosclerotic cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Subodh, Sharma, Abhinav, Zinman, Bernard, Ofstad, Anne Pernille, Fitchett, David, Brueckmann, Martina, Wanner, Christoph, Zwiener, Isabella, George, Jyothis T., Inzucchi, Silvio E., Butler, Javed, Mazer, C. David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318207/
https://www.ncbi.nlm.nih.gov/pubmed/32227432
http://dx.doi.org/10.1111/dom.14015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318207/
https://www.ncbi.nlm.nih.gov/pubmed/32227432
http://dx.doi.org/10.1111/dom.14015

Ejemplares similares